Freeing the world of musculoskeletal pain

We take pride in being a Swiss company, committed to delivering proven products and offering thoughtful guidance to our partners

Management Team

Silvia Scherer

CEO

Sylvain Ducret

Chief Financial Officer

Mark Geissler

SVP Business Development & Head of European Affiliates

Committed to reliable and flexible financial management in a dynamic environment.

Isabelle Baillet

VP Finance

Charlotte Cadoux

VP Human Ressources

Eduard Vidovic

VP Medical Affairs

Jean-Baptiste Bollard

VP Distribution Network

Our history

Founded in 2013, we have come a long way in a short period of time

01
2009

Launch of
SynolisTM VA 40/80

02
2009

European patent on crossover frequency and concentration

03
2013

Spin off Anteis - Aptissen Creation

04
2015

Subsidiary in Italy

05
2018

ISO 13485:2016

06
2018

Subsidiary in Poland

07
2019

Launch of SynolisTM VA 80/160 – CE mark

08
2019

Subsidiary in France

09
2020

MDSAP (Canada – Brazil)

10
2020

Launch of Cartylis TM

11
2023

Subsidiary in Germany

12
2023

Subsidiary in Brazil

Quality

Quality is paramount as we are dedicated to the well-being of each and every person benefiting from our products.